Literature DB >> 10514402

Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines.

P Romagnani1, A De Paulis, C Beltrame, F Annunziato, V Dente, E Maggi, S Romagnani, G Marone.   

Abstract

Eosinophils, basophils, and Th2 cells express the chemokine receptor CCR3, which binds eotaxin, RANTES, and some other chemokines. Using immunohistochemistry and flow cytometry, we demonstrate that CCR3 is also expressed by a variable proportion of human mast cells in gut, skin, and lung tissue. By contrast, with the same anti-CCR3 antibody (B711), CCR3 was poorly if at all detectable on human Th2 cells in vitro and in vivo. Eotaxin neither induced histamine release from purified human mast cells nor increased anti-IgE-stimulated histamine secretion. However, both eotaxin and RANTES elicited mast cell migration in vitro with a similar efficacy. High percentages of CCR3-expressing mast cells were present in the skin and in the intestinal submucosa; much lower percentages were found in the intestinal mucosa and in lung interstitium. Double immunostaining with anti-CCR3 and anti-chymase antibody showed that the vast majority of CCR3-expressing mast cells in the various tissues examined were tryptase-chymase double-positive. Therefore, tryptase-chymase double-positive mast cells express CCR3 and are attracted by CCR3-binding chemokines, eotaxin, and RANTES. Our findings indicate that these chemokines may play an important role in the differentiation and/or migration of this mast cell subset in connective tissues, as well as in sites of allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514402      PMCID: PMC1867029          DOI: 10.1016/S0002-9440(10)65222-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.

Authors:  R P Schleimer; H S Freeland; S P Peters; K E Brown; C P Derse
Journal:  J Pharmacol Exp Ther       Date:  1989-08       Impact factor: 4.030

2.  Development of human mast cells in vitro.

Authors:  T Furitsu; H Saito; A M Dvorak; L B Schwartz; A M Irani; J F Burdick; K Ishizaka; T Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  Mast cell heterogeneity in man. I. Histologic studies of the intestine.

Authors:  D Befus; R Goodacre; N Dyck; J Bienenstock
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

4.  Formalin sensitivity and differential staining of mast cells in human dermis.

Authors:  J S Marshall; G P Ford; E B Bell
Journal:  Br J Dermatol       Date:  1987-07       Impact factor: 9.302

5.  Two types of human mast cells that have distinct neutral protease compositions.

Authors:  A A Irani; N M Schechter; S S Craig; G DeBlois; L B Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.

Authors:  D S Robinson; Q Hamid; S Ying; A Tsicopoulos; J Barkans; A M Bentley; C Corrigan; S R Durham; A B Kay
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

7.  Chymase and tryptase in dog mastocytoma cells: asynchronous expression as revealed by enzyme cytochemical staining.

Authors:  G H Caughey; N F Viro; L D Calonico; D M McDonald; S C Lazarus; W M Gold
Journal:  J Histochem Cytochem       Date:  1988-08       Impact factor: 2.479

8.  Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function.

Authors:  A M Irani; S S Craig; G DeBlois; C O Elson; N M Schechter; L B Schwartz
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

9.  Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves.

Authors:  R H Stead; M Tomioka; G Quinonez; G T Simon; S Y Felten; J Bienenstock
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

10.  Mutual phenotypic changes between connective tissue type and mucosal mast cells.

Authors:  Y Kitamura; Y Kanakura; S Sonoda; H Asai; T Nakano
Journal:  Int Arch Allergy Appl Immunol       Date:  1987
View more
  33 in total

1.  Protective effect of eotaxin-2 inhibition in adjuvant-induced arthritis.

Authors:  J N Ablin; M Entin-Meer; V Aloush; S Oren; O Elkayam; J George; I Barshack
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

Review 2.  G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation.

Authors:  Hye Sun Kuehn; Alasdair M Gilfillan
Journal:  Immunol Lett       Date:  2007-09-18       Impact factor: 3.685

Review 3.  Chemokines and their receptors as potential targets for the treatment of asthma.

Authors:  C Palmqvist; A J Wardlaw; P Bradding
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

4.  Trophoblasts-derived chemokine CCL24 promotes the proliferation, growth and apoptosis of decidual stromal cells in human early pregnancy.

Authors:  Hui Li; Yuan-Hua Huang; Ming-Qing Li; Yu-Han Meng; Xuan Chen; Jun Shao; Chuan-Ling Tang; Mei-Rong Du; Li-Ping Jin; Da-Jin Li
Journal:  Int J Clin Exp Pathol       Date:  2013-05-15

5.  Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E.

Authors:  A Genovese; J P Bouvet; G Florio; B Lamparter-Schummert; L Björck; G Marone
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

6.  Increased CCL24/eotaxin-2 with postnatal ozone exposure in allergen-sensitized infant monkeys is not associated with recruitment of eosinophils to airway mucosa.

Authors:  Debbie L Chou; Joan E Gerriets; Edward S Schelegle; Dallas M Hyde; Lisa A Miller
Journal:  Toxicol Appl Pharmacol       Date:  2011-09-12       Impact factor: 4.219

7.  Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut.

Authors:  F Qadri; T R Bhuiyan; K K Dutta; R Raqib; M S Alam; N H Alam; A-M Svennerholm; M M Mathan
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

8.  Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade.

Authors:  Dai Miyazaki; Takao Nakamura; Masaharu Ohbayashi; Chuan Hui Kuo; Naoki Komatsu; Keiko Yakura; Takeshi Tominaga; Yoshitsugu Inoue; Hidemitsu Higashi; Meguru Murata; Shuzo Takeda; Atsuki Fukushima; Fu-Tong Liu; Marc E Rothenberg; Santa Jeremy Ono
Journal:  Int Immunol       Date:  2009-01-15       Impact factor: 4.823

9.  The function of CCR3 on mouse bone marrow-derived mast cells in vitro.

Authors:  Sarah J Collington; John Westwick; Timothy J Williams; Charlotte L Weller
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

10.  The airway smooth muscle CCR3/CCL11 axis is inhibited by mast cells.

Authors:  R Saunders; A Sutcliffe; L Woodman; D Kaur; S Siddiqui; Y Okayama; A Wardlaw; P Bradding; C Brightling
Journal:  Allergy       Date:  2008-09       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.